Immediate Impact
1 by Nobel laureates 50 standout
Citing Papers
Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment
2024 Standout
Immunogenic cell stress and death
2022 Standout
Works of Michael Kersten being referenced
Identification of markers for the selection of patients undergoing renal cell carcinoma‐specific immunotherapy
2003
Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma.
2000
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Michael Kersten | 175 | 67 | 87 | 76 | 13 | 382 | |
| Josphin Johnson | 137 | 18 | 25 | 30 | 8 | 349 | |
| Stéphanie Dubois | 154 | 25 | 90 | 73 | 14 | 428 | |
| Anders Christiansen | 211 | 67 | 32 | 11 | 17 | 407 | |
| Juan J. Bustamante | 154 | 26 | 32 | 43 | 24 | 450 | |
| O.E. Dadzie | 87 | 10 | 70 | 37 | 23 | 446 | |
| Adam L. Haber | 153 | 30 | 24 | 76 | 15 | 368 | |
| Lisa Walker | 186 | 10 | 31 | 47 | 12 | 458 | |
| France Landry | 201 | 94 | 72 | 26 | 19 | 431 | |
| Christien Kluwe | 205 | 43 | 24 | 40 | 10 | 392 | |
| Ana Cristina da Silva do Amaral Herrera | 134 | 25 | 125 | 61 | 22 | 356 |
All Works
Loading papers...